Volume 7, Number 3—June 2001
Research
Goat-Associated Q Fever: A New Disease in Newfoundland
Table 2
Features and symptoms | Infected no. (%) | Noninfected no. (%) | Odds ratio (95% CI) |
---|---|---|---|
Male | 31/58 (53.4) | 46/88 (52.3) | 1.05 (0.154-2.04) |
Female | 27/58 (46.6) | 42/88 (47.7) | |
Mean age | 38.48 ± 11.76 | 33.47 ± 19.34 | p=0.054 |
Sick in the past 2 months | 49/60 (81.7) | 48/86 (55.8) | 3.53 (1.62-7.70) |
Symptoms | |||
Sweats | 11/12 (91.7) | 3/9 (33.3) | 22.0 (1.86-260.5) |
Chills | 12/14 (85.7) | 4/10 (40.0) | 9.00 (1.27-63.90) |
Headache | 43/60 (71.7) | 20/78 (25.6) | 7.34 (3.44-15.64) |
Malaise | 44/59 (74.6) | 28/77 (36.4) | 5.13 (2.43-10.84) |
Weight loss | 8/31 (25.8) | 3/43 (7.0) | 4.64 (1.12-19.24) |
Fever | 40/60 (66.7) | 25/79 (31.6) | 4.32 (2.11-8.84) |
Fatigue | 39/58 (67.2) | 27/79 (34.2) | 3.95 (1.93-8.11) |
Myalgias | 26/58 (44.8) | 15/76 (19.7) | 3.30 (1.54-7.11) |
Dyspnea | 19/60 (31.7) | 12/78 (15.4) | 2.55 (1.12-5.79) |
Nausea | 30/60 (50.0) | 22/80 (27.5) | 2.24 (1.30-5.34) |
Diarrhea | 23/60 (38.3) | 18/81 (22.2) | 2.18 (1.04-4.55) |
Cognitivea | 14/30 (46.7) | 4/15 (26.7) | 2.41 (0.62-9.29) |
Sputum | 13/46 (22.0) | 11/78 (14.1) | 1.72 (0.71-4.18) |
EOM pain | 8/15 (53.3) | 4/9 (44.4) | 1.43 (0.27-7.52) |
Neck stiffness | 16/22 (72.7) | 9/14 (64.3) | 1.43 (0.27-7.52) |
Vomiting | 12/60 (20.0) | 15/81 (18.5) | 1.10 (0.47-2.56) |
Pleuriti pain | 8/57 (14.0) | 10/76 (13.2) | 1.08 (0.40-2.93) |
Cough | 22/60 (36.7) | 28/81 (34.6) | 1.10 (0.55-2.20) |
Loss of libido | 13/32 (40.6) | 5/12 (41.7) | 0.96 (0.25-3.38) |
aCognitive, problems including changes in concentration, memory, or temper. EOM, extra-ocular eye movement; CI, confidence intervals.
Page created: April 26, 2012
Page updated: April 26, 2012
Page reviewed: April 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.